(Q35102439)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

6 August 2017

0 references

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies (English)

1 reference

6 August 2017

main subject

hepatocellular carcinoma

1 reference

1 reference

Yong-Shuang Li

1

1 reference

6 August 2017

Qiang Xie

series ordinal

2

1 reference

6 August 2017

Da-Ye Yang

series ordinal

3

1 reference

6 August 2017

Yuan Zheng

series ordinal

4

1 reference

6 August 2017

publication date

25 February 2014

1 reference

Molecular Biology Reports

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

3925-3933

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-014-3260-0

6 August 2017

exact match

0 references

cites work

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Molecular mechanism of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

The role of RASSF1A in uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

RASSF1A: a potential novel therapeutic target against cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Comparison of two methods to detect publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Protein kinase A-mediated phosphorylation of the RASSF1A tumour suppressor at Serine 203 and regulation of RASSF1A function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Tumor suppressor RASSF1A promoter: p53 binding and methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3260-0

Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma

1 reference

12 December 2020

The RASSF proteins in cancer; from epigenetic silencing to functional characterization

1 reference

12 December 2020

Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA

1 reference

12 December 2020

HEGESMA: genome search meta-analysis and heterogeneity testing

1 reference

12 December 2020

RASSF1A hypermethylation is associated with aflatoxin B1 and polycyclic aromatic hydrocarbon exposure in hepatocellular carcinoma

1 reference

12 December 2020

An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

1 reference

12 December 2020

RASSF1A promoter hypermethylation as a prognostic marker for hepatocellular carcinoma

1 reference

12 December 2020

Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors

1 reference

12 December 2020

10.1007/S11033-014-3260-0

Identifiers

DOI

1 reference

6 August 2017

1 reference